Verrica Pharmaceuticals Inc. (VRCA)
Verrica Pharmaceuticals Inc. (VRCA)
$14.00 USD
Updated Sep 19 6:55pm
Add VRCA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
VRCA Stock Chart More Charts
VRCA Price/Volume Stats
| Current price | $14.00 |
| Prev. close | $14.47 |
| Day low | $13.83 |
| Day high | $15.06 |
| 50-day MA | $10.79 |
| 200-day MA | $10.46 |
| 52-week high | $17.63 |
| 52-week low | $6.44 |
| Volume | 82,300 |
| Avg. volume | 52,176 |
| Dividend yield | N/A |
| Market Cap | 360.37M |
Verrica Pharmaceuticals Inc. (VRCA) Company Bio
Verrica Pharmaceuticals Inc. develops and commercializes dermatological treatments in the United States. The company is advancing its lead product VP-102, a proprietary topical therapy, in various common skin indications, including Molluscum contagiosum and Verruca Vulgaris. It is also developing 2 Phase 3 trials in molluscum contagiosum under NCT03377803 and NCT03377790. The company is based in West Chester, Pennsylvania.
Top Stories View All
Best & Worst Performing Stock Industries for September 19, 2019
Best & Worst Performing Small Cap Stocks for September 19, 2019
Best & Worst Performing Mid Cap Stocks for September 19, 2019
Best & Worst Performing Large Cap Stocks for September 19, 2019
Best & Worst Performing Mega Cap Stocks for September 19, 2019
View All Top Stories
Loading social stream, please wait...